ABCSG 31/ALTTO Summary
Randomized, multi-center, open-label, phase-III-study of adjuvant lapatinib, trastuzumab, their sequence and their combination in patients with HER2/ErbB2-positive primary breast cancer.
|Coordinating investigator:||Gnant, Michael; Vienna|
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.